Physician profile
David Mckenna
NPI 1215538913
$804.25
in general payments reported to CMS, 2019-2025
16 companies · $229 in 2025
The $229 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $37.36 · 2023: $190 · 2024: $347 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $197.63 | 2023-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $148.14 | 2023-2025 | |
| Lilly USA, LLC | $73.22 | 2023-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $53.64 | 2023-2024 | Ozempic, Rybelsus |
| Pfizer INC. | $45.66 | 2022-2024 | |
| Xeris Pharmaceuticals, INC. | $41.66 | 2024-2025 | Gvoke Hypopen |
| Novartis Pharmaceuticals Corporation | $40.56 | 2023-2025 | |
| Vanda Pharmaceuticals INC. | $39.33 | 2024-2025 | Hetlioz, Fanapt |
| Glaxosmithkline, LLC. | $32.88 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.61 | 2025 | Caplyta |
| Scilex Pharmaceuticals INC. | $22.68 | 2022 | |
| Boston Scientific Corporation | $18.44 | 2024 | Wavewriter Alpha Prime 16 |
| Dexcom, INC. | $17.95 | 2024 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $17.55 | 2025 | Inspire |
| Janssen Pharmaceuticals, INC | $17.40 | 2023 | Spravato |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $13.90 | 2023 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mckenna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.